iNEXT is a consortium funded by the Horizon2020 program to offer European researchers access to a wide range of advanced structural biology technologies, including X-ray technologies, NMR spectroscopy, Electron Microscopy and Biophysics, in large European infrastructures.
iNEXT offers access to infrastructures to study the structure and function of biological macromolecules and their assemblies, and aspires to promote biomedicine, biotechnology, and biomaterials, involving scientists with or without previous experience in structural biology.
iNEXT follows the revolution in cryo-electron microscopy, offering for the first time transnational access to high-end transmission electron microscopes. Access to biophysics facilities to study macromolecular interactions in cells and in vivo, is also offered for the first time.
All European researchers can apply for transnational access to perform their Structural Biology research at one of facilities involved. Proposals should originate from an EU-country or associated country: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom, Iceland, Norway, Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro, Serbia, Turkey, Israel, Moldova, Switzerland, Faroe Islands, Ukraine.
We welcome proposals that aim to advance science in Biomedicine, Biotechnology, and Biomaterials by providing new knowledge about structure and function of biological macromolecules and their assemblies.
The iNEXT consortium involves 23 partners from 14 different European countries. Training and networking activities are carried out to attract new users and to disseminate scientific results across academia and industry.
Funded from the Horizon 2020 programme of the European Union, iNEXT (H2020 project #653706) is the first research infrastructure project that combines access to different structural biology technologies (SAXS, X-ray crystallography, NMR, EM, biophysical characterization).